Allspring Global Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28,785
| Closed | -$54.7K | – | 2449 |
|
|
2024
Q2 | $54.7K | Buy |
28,785
+13,509
| +88% | +$25.7K | ﹤0.01% | 1953 |
|
|
2024
Q1 | $43.4K | Buy |
15,276
+15,247
| +52,576% | +$43.3K | ﹤0.01% | 1969 |
|
|
2023
Q4 | $426 | Sell |
29
-14,158
| -100% | -$208K | ﹤0.01% | 2154 |
|
|
2023
Q3 | $260K | Sell |
14,187
-2,607
| -16% | -$47.7K | ﹤0.01% | 1690 |
|
|
2023
Q2 | $362K | Sell |
16,794
-260,994
| -94% | -$5.63M | ﹤0.01% | 1637 |
|
|
2023
Q1 | $8.15M | Buy |
277,788
+11,769
| +4% | +$345K | 0.01% | 843 |
|
|
2022
Q4 | $9.83M | Sell |
266,019
-3,479
| -1% | -$129K | 0.02% | 786 |
|
|
2022
Q3 | $7.59M | Sell |
269,498
-145,800
| -35% | -$4.1M | 0.01% | 860 |
|
|
2022
Q2 | $8M | Buy |
415,298
+12,974
| +3% | +$250K | 0.01% | 839 |
|
|
2022
Q1 | $5.17M | Buy |
+402,324
| New | +$5.17M | 0.01% | 1132 |
|